Sort by
Keyphrases
Transgenic Mice
100%
Transgenic
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Memory Deficits
100%
Glycogen Synthase Kinase 3 (GSK3)
100%
Sex-dependent
100%
Contextual Fear Memory
100%
HIV-associated Neurocognitive Disorders
37%
HIV Patients
25%
Wild Mice
25%
Synapsin
25%
Basal Synaptic Transmission
25%
GluA1
25%
Mouse Model
12%
Quantitative PCR
12%
Antiretroviral Therapy
12%
MRNA Expression
12%
Immunohistochemistry
12%
Synaptic
12%
Synaptic Mechanisms
12%
Neuronal Loss
12%
Microglial Activation
12%
Synaptic Plasticity
12%
Electrophysiology
12%
Sex Differences
12%
Hippocampal Neurons
12%
Fear Conditioning
12%
Biological Sex
12%
Western Blot
12%
Littermate
12%
PCR Method
12%
ELISA Method
12%
Phosphorylation State
12%
Area CA1
12%
Benzyl
12%
Long Terminal Repeat
12%
AMPA-type Glutamate Receptor
12%
Potential Therapeutic Strategies
12%
Thiazolidine-2,4-dione
12%
BDNF Protein
12%
Memory Plasticity
12%
BDNF mRNA
12%
Conditioning Paradigms
12%
2-methyl-1
12%
LTP Induction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Transgenic Mouse
100%
Human Immunodeficiency Virus 1
100%
Glycogen Synthase Kinase 3
100%
HIV
80%
HIV Associated Dementia
60%
Wild Type Mouse
40%
Brain Derived Neurotrophic Factor
40%
Synapsin I
40%
Messenger RNA
40%
Mouse Model
20%
Enzyme-Linked Immunosorbent Assay
20%
Western Blot
20%
Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid
20%
Glutamate Receptor
20%
Neuroscience
Glycogen Synthase Kinase 3
100%
Human Immunodeficiency Virus
100%
HIV Associated Dementia
60%
Brain-Derived Neurotrophic Factor
40%
Synapsin I
40%
Synaptic Transmission
40%
Messenger RNA
40%
Synaptic Plasticity
20%
ELISA
20%
Western Blot
20%
Fear Conditioning
20%
Glutamate Receptor
20%
LTP Induction
20%
AMPA
20%
Immunohistochemistry
20%
Long Terminal Repeat
20%
Electrophysiology
20%